SCHEMBL8826323

SCHEMBL8826323

CCCNC(=O)c1ccc2oc3ccccc3c2c1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
MAPT P10636 1/20 0.56
BCAT1 P54687 6/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
KDM4E B2RXH2 2/20 0.51
MAOB P27338 1/20 0.51
LMNA P02545 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ROCK2 O75116 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
MCHR1 Q99705 1/20 0.48
POLB P06746 1/20 0.48
TTR P02766 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1491962 0.87 BCAT1 (0.53) ALDH1A1MAPTBCAT1KDM4ELMNA
SCHEMBL4226088 0.84 NPC1 (0.60) MAOBNPC1RAB9ATTRSMN1; SMN2
SCHEMBL26116873 0.83 BCAT1 (0.57) ALDH1A1MAPTBCAT1KDM4ELMNA
SCHEMBL13044619 0.83 MCHR1 (0.49) ALDH1A1MAPTBCAT1LMNANPC1
SCHEMBL26570393 0.82 BCAT1 (0.51) ALDH1A1BCAT1KDM4ELMNANPC1
SCHEMBL6235025 0.82 BCAT1 (0.59) ALDH1A1MAPTBCAT1KDM4ELMNA
SCHEMBL26575703 0.82 BCAT1 (0.53) ALDH1A1MAPTBCAT1KDM4ELMNA
Trifluoroacetic Acid SCHEMBL29887191 0.80 TP53 (0.50) ALDH1A1BCAT1L3MBTL1KDM4ELMNA
SCHEMBL11599094 0.78 NPC1 (0.57) ALDH1A1MAPTBCAT1KDM4ELMNA
SCHEMBL11352725 0.77 TTR (0.54) ALDH1A1MAPTBCAT1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5631401-A Inhibitors of protein farnesyltransferase and squalene synthase ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
WO-1995021815-A1 CYCLOBUTANE DERIVATIVES AND THEIR USE AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE AND SQUALENE SYNTHASE ABBOTT LABORATORIES (US) 1995-08-17 WO disclosed